Rating History for Alnylam Pharmaceuticals (ALNY) by William Blair
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/7/2022 | Myles Minter | New Coverage | Outperform (N/A) |
N/A (N/A) |
131.63 (143.87) |
9.3% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/7/2022 | Myles Minter | New Coverage | Outperform (N/A) |
N/A (N/A) |
131.63 (143.87) |
9.3% | Details |
